within Pharmacolibrary.Drugs.ATC.G;

model G04BD01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 8.4 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Emepronium is a quaternary ammonium compound formerly used as an antimuscarinic agent to relieve urinary urgency and incontinence, mostly associated with spasms of the urinary tract. Its clinical use has largely been discontinued in many countries due to rare but serious adverse effects including esophageal ulceration.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters found for emepronium in the literature for any population. The following values are rough estimates based on the physicochemical properties of quaternary ammonium drugs and general knowledge about the class.</p><h4>References</h4><ol><li><p>Pilbrant, A, &amp; Norlén, LJ (1985). Pharmacokinetics and pharmacodynamics of emepronium bromide (Cetiprin) after intravenous administration in man. <i>Acta pharmacologica et toxicologica</i> 56(4) 289–297. DOI:<a href=&quot;https://doi.org/10.1111/j.1600-0773.1985.tb01292.x&quot;>10.1111/j.1600-0773.1985.tb01292.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4024956/&quot;>https://pubmed.ncbi.nlm.nih.gov/4024956</a></p></li><li><p>Hallén, B, &amp; Sundwall, A (1987). Gastrointestinal transit rate-related absorption of emepronium: a study in mice. <i>Pharmacology &amp; toxicology</i> 60(3) 199–205. DOI:<a href=&quot;https://doi.org/10.1111/j.1600-0773.1987.tb01733.x&quot;>10.1111/j.1600-0773.1987.tb01733.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3588514/&quot;>https://pubmed.ncbi.nlm.nih.gov/3588514</a></p></li><li><p>Sundwall, A, et al., &amp; Strindberg, B (1973). Fate of emepronium in man in relation to its pharmacological effects. <i>European journal of clinical pharmacology</i> 6(3) 191–195. DOI:<a href=&quot;https://doi.org/10.1007/BF00558285&quot;>10.1007/BF00558285</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4762058/&quot;>https://pubmed.ncbi.nlm.nih.gov/4762058</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G04BD01;
